Advances in omalizumab treatment for IgE-mediated food allergies
The increasing prevalence of food allergies significantly affects both the physical and mental health of patients, while concurrently imposing a substantial economic burden on a global scale. Immunoglobulin E (IgE)-mediated food allergies typically manifest as acute reactions and may lead to severe...
Saved in:
| Main Authors: | Siqi WANG, Ling YE, Meiling JIN |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shanghai Chinese Clinical Medicine Press Co., Ltd.
2025-08-01
|
| Series: | Zhongguo Linchuang Yixue |
| Subjects: | |
| Online Access: | https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2025.20241062 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Omalizumab in Food Allergy in Children: Current Evidence and Future Perspectives
by: Cristiana Indolfi, et al.
Published: (2025-04-01) -
Omalizumab and Oral Immunotherapy in IgE-Mediated Food Allergy in Children: A Systematic Review and a Meta-Analysis
by: Enrico Vito Buono, et al.
Published: (2025-03-01) -
GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management
by: Torsten Zuberbier, et al.
Published: (2024-11-01) -
Anti-IgE therapy versus allergen-specific immunotherapy for food allergy: weighing the pros and cons
by: Michael D. Kulis, et al.
Published: (2025-07-01) -
Non-IgE-dependent food allergies in children
by: Yu. G. Zaitseva, et al.
Published: (2021-06-01)